Placebo Oral Tablet clinical trials
9 indexed studies · 5 currently recruiting
- Active not recruitingPHASE3
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
This study is for women with advanced ovarian cancer who've had their first treatment. It's testing if two medications, rucaparib and nivolumab, given after initial treatment, can help prevent the cancer from returning or growing. It compares these drugs to dummy treatments.
For: Epithelial Ovarian Cancer · Primary Peritoneal · Fallopian Tube CancerUnited States · Australia · Belgium - Active not recruitingPHASE3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
This study is for adults with a type of blood cancer called follicular lymphoma, which has come back or isn't responding to treatment. It compares a new drug (Tazemetostat) with existing treatments to see if it's safe and helps people live longer without their cancer getting worse.
For: Relapsed/Refractory Follicular Lymphoma · Follicular Lymphoma · Refractory Follicular LymphomaUnited States · Australia · Belgium - Active not recruitingPHASE4
A Study of Cardiovascular Events iN Diabetes Plus
This study is for people with type 2 diabetes who haven't had a heart attack or stroke. It checks if a tablet called semaglutide can safely lower risks of heart problems, strokes, and death from heart issues over about 5 years, all done from home.
For: Diabetes Mellitus, Type 2United Kingdom - RecruitingNA
Measurement of the Hippocampal Theta Rhythm From the Outer Ear Canal
This study explores a new, non-invasive way to measure brain activity linked to anxiety directly from your ear. We are testing if special ear sensors can detect a specific brain rhythm (theta) that changes when people are anxious, potentially leading to better anxiety diagnosis.
For: AnxietyCanada - RecruitingPHASE3
Statins for Venous Event Reduction in Patients With Venous Thromboembolism
This study looks at whether adding a common cholesterol-lowering drug called a statin (rosuvastatin) to standard blood thinner treatment can prevent new blood clots and reduce vein damage after a deep vein thrombosis or pulmonary embolism. Some people will get the statin, while others get a dummy pill.
For: Venous Thromboembolism · Blood Clot · Post Thrombotic SyndromeCanada · France · Ireland - RecruitingPHASE3
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
This study looks at how well a 1mg minoxidil tablet works for women with hair loss. It compares it to a minoxidil skin solution and a dummy tablet, also checking its safety. It runs for 36 weeks.
For: Androgenetic Alopecia · Female Pattern BaldnessGermany - RecruitingPHASE3
ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty
This study looks at how long people need blood thinners after hip replacement surgery. It compares taking them for 10 days versus 35 days to see if the shorter time is just as safe for preventing blood clots.
For: Hip Arthroplasty, Total · Prevention of Venous ThromboembolismAustria · Germany - Active not recruitingPHASE3
Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate
This study looks at a new drug called darolutamide, along with standard treatments like radiotherapy and hormone therapy, for men with prostate cancer that's at a very high risk of coming back. The aim is to see if this combination can better stop the cancer from spreading and improve their long-term health.
For: Prostate CancerUnited States · Australia · Canada - RecruitingPHASE3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
This study looks at a new drug, acoramidis, for people who have a faulty gene that can cause a condition called ATTR. It aims to see if the drug can stop or slow down the disease from developing in people who don't yet have symptoms.
For: Amyloidosis · Amyloid Cardiomyopathy · Transthyretin AmyloidosisUnited States · Argentina · Australia